1.Clinical Application of the Dual Energy Photon Beam Using 6 MV and 10 MV X-ray.
Journal of the Korean Society for Therapeutic Radiology 1988;6(1):93-100
Some modern accerelators provide a dual energy for photon beam treatment. The main advantages of dual energy in the treatment of rectosigmoid or rectal cancer are as follows. Dose in the critical organ such as small intestine, bladder and genital organ are reduced. Presacral and perineal area is fully covered. Dose distribution analysis such as calculation of dose in a target volume, isocenter, Dmax and dose spectrum in any region of interest are possible. Examples of plan are given and results are discussed.
Genitalia
;
Intestine, Small
;
Rectal Neoplasms
;
Urinary Bladder
2.The lived experience of health-management in patients with Parkinson’s disease
Hye Gyeong SON ; Hyun-Joo PARK ; Sang Jin KIM ; A-Leum HAN
Journal of Korean Academic Society of Nursing Education 2020;26(4):423-433
Purpose:
The purpose of this study was to describe the health care experiences among patients with Parkinson’s disease.
Methods:
Of the qualitative research methods, Colaizzi’s phenomenological method was used in this study. A total of nine patients, who were diagnosed with Parkinson’s disease and receiving outpatient treatment, were selected as the subjects of this study. Subsequently, data were collected through individual in-depth interview.
Results:
The four categories obtained as a result were ‘strenuous efforts to control my own body,’ ‘subject of health that no one can replace,’ ‘focus on the current while expecting a breakthrough in health management,’ and ‘human dignity that cannot be lost to the end.’
Conclusion
The study results are expected to help health care providers deeply understand the experiences in health care among patients with Parkinson’s disease and to provide source data for nursing intervention development that can be helpful in managing the health status of patients with Parkinson’s disease.
3.Long-term Outcome of Trigeminal Nerve Block with Alcohol for the Treatment of Trigeminal Neuralgia.
Kyung Ream HAN ; Chan KIM ; Do Wan KIM ; Oi Gyeong CHO ; Hye Won CHO
The Korean Journal of Pain 2006;19(1):45-50
BACKGROUND: Recently trigeminal nerve block with alcohol (TnbA) for the treatment of trigeminal neuralgia (TN) has come to be known as a procedure with a short-term effect and high complications. There has been none of report about long-term outcome of TnbA for TN. The objective of this prospective study for the long-term results of TnbA was to analyse the pain free duration and complication after the administration of blocks and compare them in the first block and subsequent blocks. METHODS: From March 1996 to May 2005, 304 consecutive patients with primary trigeminal neuralgia were treated with TnbA including supraorbital nerve block, infraorbital nerve block, maxillary nerve (V2) block, mandibular nerve (V3) block, and V2 and V3 at the same time and were prospectively followed up every two months for 10 years. RESULTS: The mean value of pain free duation of 1st, 2nd and 3rd TnbA were 43, 38 and 48 months, respectively using Kaplan-Meier analysis. The probability of pain recurrence in 1 and 3 years after the 1st, 2nd and 3rd blocks were 25%, 25%, 20% and 53%, 54%, 34%, respectively. The pain free durations of first and subsequent blocks were not statistically different. Complications were reported at 36 (11.8%), 5 (4.2%), and 0 in 1st, 2nd and 3rd blocks. CONCLUSIONS: TnbA showed the relatively long duration of pain free and low incidence of complications. Repeated TnbA has pain free duration as long as the 1st block and less complications as well. TnbA is a valuable treatment of TN as a percutaneous procedure.
Humans
;
Incidence
;
Kaplan-Meier Estimate
;
Mandibular Nerve
;
Maxillary Nerve
;
Nerve Block
;
Prospective Studies
;
Recurrence
;
Trigeminal Nerve*
;
Trigeminal Neuralgia*
4.Percutaneous Discectomy of Herniated Intervertebral Disc with a Dekompressor(R).
Oi Gyeong CHO ; Chan KIM ; Kyung Ream HAN ; Hyun Ho LEE ; Hye Won CHO
The Korean Journal of Pain 2005;18(2):192-197
BACKGROUND: Radicular pain, associated with herniated intervertebral disc, has been treated with either conservative treatments or a traditional surgical discectomy. Several modalities for minimally invasive percutaneous procedures have been developed as alternatives to a surgical discectomy. Percutaneous decompression using a Dekompressor(R) probe has been recently introduced. Herein, we report the outcome of percutaneous decompression with a Dekompressor(R) for the treatment of a herniated intervertebral disc. METHODS: Between August 2004 and April 2005, percutaneous decompression was performed using a Dekompressor(R), 1.5-mm percutaneous lumbar discectomy probe in 17 patients with a herniated lumbar intervertebral disc resistant to conservative treatments, with the results reviewed retrospectively. The procedure was performed under fluoroscopic guidance after local anesthesia. Disc access was gained with a posterolateral approach on the symptomatic side and intradiscal placement of the discectomy probe in the herniated disc confirmed from the anteroposterior and lateral views on the fluoroscopy. RESULTS: We obtained satisfactory clinical results in 14 patients with a decrease in the initial Visual analogue scale (VAS) of more than 55% and the elimination or reduction of analgesic medication, with a follow-up of 3 to 11 months. CONCLUSION: We concluded that a percutaneous discectomy with a Dekompressor(R) probe might be an effective alternative for the treatments of painful disc herniations resistant to conservative managements when performed under proper selection criteria.
Anesthesia, Local
;
Decompression
;
Diskectomy
;
Diskectomy, Percutaneous*
;
Fluoroscopy
;
Follow-Up Studies
;
Humans
;
Intervertebral Disc Displacement
;
Intervertebral Disc*
;
Patient Selection
;
Retrospective Studies
5.Erratum: Anthropometric Study of the Stomach.
Eun Gyeong LEE ; Tae Han KIM ; Yeon Ju HUH ; Yun Suhk SUH ; Hye Sung AHN ; Seong Ho KONG ; Hyuk Joon LEE ; Woo Ho KIM ; Han Kwang YANG
Journal of Gastric Cancer 2017;17(3):282-282
The authors found out that this article was omitted “Funding section” for grant support.
6.Anthropometric Study of the Stomach.
Eun Gyeong LEE ; Tae Han KIM ; Yeon Ju HUH ; Yun Suhk SUH ; Hye Sung AHN ; Seong Ho KONG ; Hyuk Joon LEE ; Woo Ho KIM ; Han Kwang YANG
Journal of Gastric Cancer 2016;16(4):247-253
PURPOSE: The aim of this study was to establish an anthropometric reference of the stomach for gastric cancer surgery and a modeling formula to predict stomach length. MATERIALS AND METHODS: Data were retrieved for 851 patients who underwent total gastrectomy at the Seoul National University Hospital between 2008 and 2013. Clinicopathological data and measurements from a formalin-fixed specimen were reviewed. The lengths (cm) of the greater curvature (GC) and lesser curvature (LC) were measured. Anthropometric data of the stomach were compared according to age, body weight, height (cm), and body mass index. To predict stomach length, two multiple regression analyses were performed. RESULTS: The mean lengths of the GC and LC were 22.2±3.1 cm and 16.3±2.6 cm, respectively. The men’s GC length was significantly greater than the women’s (22.4±3.1 cm vs. 21.2±2.9 cm, P=0.003). Patients aged >70 years showed significantly longer LC than those aged <50 years (16.9±2.9 cm vs. 15.9±2.4 cm, P=0.002). Patients with body weights >70 kg showed significantly longer GC than those with body weights <55 kg (23.0±2.9 cm vs. 21.4±3.2cm, P<0.001). In the predicted models, 4.11% of the GC was accounted for by age and weight; and 4.94% of the LC, by age, sex, height, and weight. CONCLUSIONS: Sex, age, height, and body weight were associated with the length of the LC, while sex and body weight were the only factors that were associated with the length of the GC. However, the prediction model was not sufficiently strong.
Body Mass Index
;
Body Weight
;
Gastrectomy
;
Humans
;
Organ Size
;
Seoul
;
Stomach Neoplasms
;
Stomach*
7.Schisandra Chinensis Baillon regulates the gene expression of phase II antioxidant/detoxifying enzymes in hepatic damage induced rats.
Han I JANG ; Gyeong Min DO ; Hye Min LEE ; Hyang Mok OK ; Jae Ho SHIN ; Oran KWON
Nutrition Research and Practice 2014;8(3):272-277
BACKGROUND/OBJECTIVES: This study investigated the antioxidant activities and hepatoprotective effects of Schisandra chinensis Baillon extract (SCE) against tert-butyl hydroperoxide (t-BHP)-induced oxidative hepatic damage in rats. MATERIALS/METHODS: Sprague-Dawley (SD) rats were pretreated with SCE (300, 600, and 1,200 mg/kg BW) or saline once daily for 14 consecutive days. On day 14, each animal, except those belonging to the normal control group, were injected with t-BHP (0.8 mmol/kg BW/i.p.), and all of the rats were sacrificed 16 h after t-BHP injection. RESULTS: Although no significant differences in AST and ALT levels were observed among the TC and SCE groups, the high-dose SCE group showed a decreasing tendency compared to the TC group. However, erythrocyte SOD activity showed a significant increase in the low-dose SCE group compared with the TC group. On the other hand, no significant differences in hepatic total glutathione (GSH) level, glutathione reductase (GR), and glutathione peroxidase (GSH-Px) activities were observed among the TC and SCE groups. Hepatic histopathological evaluation revealed that pretreatment with SCE resulted in reduced t-BHP-induced incidence of lesions, such as neutrophil infiltration, swelling of liver cells, and necrosis. In particular, treatment with a high dose of SCE resulted in induction of phase II antioxidant/detoxifying enzyme expression, such as glutathione S-transferase (GST) and glutamate-cysteine ligase catalytic subunit (GCLC). CONCLUSIONS: Based on these results, we conclude that SCE exerts protective effects against t-BHP induced oxidative hepatic damage through the reduction of neutrophil infiltration, swelling of liver cells, and necrosis. In addition, SCE regulates the gene expression of phase II antioxidant/detoxifying enzymes independent of hepatic antioxidant enzyme activity.
Animals
;
Catalytic Domain
;
Erythrocytes
;
Gene Expression*
;
Glutamate-Cysteine Ligase
;
Glutathione
;
Glutathione Peroxidase
;
Glutathione Reductase
;
Glutathione Transferase
;
Hand
;
Incidence
;
Liver
;
Necrosis
;
Neutrophil Infiltration
;
Rats*
;
Rats, Sprague-Dawley
;
Schisandra*
;
tert-Butylhydroperoxide
8.Effect of Trendelenburg position on right and left internal jugular vein cross-sectional area.
Jeong Gil LEE ; Hee Bin PARK ; Hye Young SHIN ; Ju Deok KIM ; Soo Bong YU ; Doo Sik KIM ; Sie Jeong RYU ; Gyeong Han KIM
Korean Journal of Anesthesiology 2014;67(5):305-309
BACKGROUND: Unlike the right internal jugular vein (RIJV), there is a paucity of data regarding the effect of the Trendelenburg position on the left internal jugular vein (LIJV). The purpose of this study is to investigate the cross-sectional area (CSA) of the LIJV and RIJV and their response to the Trendelenburg position using two-dimensional ultrasound in adult subjects. METHODS: This study enrolled fifty-eight patients with American Society of Anesthesiologists physical status class I-II who were undergoing general anesthesia. CSAs of both the RIJV and LIJV were measured with a two-dimensional ultrasound in the supine position and then in a 10degrees Trendelenburg position. RESULTS: In the supine position, the transverse diameter, anteroposterior diameter, and CSA of the RIJV were significantly larger than those of the LIJV (P < 0.001). Of 58 patients, the RIJV CSA was larger than the LIJV CSA in 43 patients (74.1%), and the LIJV CSA was larger than the RIJV CSA in 15 patients (25.9%). In the Trendelenburg position, CSAs of the RIJV and LIJV increased 39.4 and 25.5%, respectively, compared with the supine position. However, RIJV changed at a rate that was significantly greater than that of the LIJV (P < 0.05). Of 58 patients, the RIJV CSA was larger than the LIJV CSA in 48 patients (82.8%), and the LIJV CSA was larger than the RIJV CSA in 10 patients (17.2%). CONCLUSIONS: In supine position, the RIJV CSA was larger than the LIJV CSA. The increased CSA in the Trendelenburg position was greater in the RIJV than the LIJV.
Adult
;
Anesthesia, General
;
Central Venous Catheters
;
Head-Down Tilt*
;
Humans
;
Jugular Veins*
;
Supine Position
;
Ultrasonography
9.Analysis of Tumor Size between Imaging of Preoperative Ultrasound, MRI and Pathologic Measurements in Early Breast Carcinoma
Eun Hyeok KIM ; Chan Gyun PARK ; Eun Hye CHOI ; Ye Jeong KIM ; Mi Jin KIM ; Kyu Dam HAN ; Young Sam PARK ; Cheol Seung KIM ; Kyun Hui NO ; Eun Ae YU ; Gyeong Gyun NA
Journal of Breast Disease 2020;8(1):19-24
Purpose:
Preoperative tumor size is associated with clinical stage, treatment plan and even survival rate of patient. We investigated the accuracy of tumor size estimation between magnetic resonance imaging (MRI) and ultrasonography (US) findings, comparing these with pathologic tumor size in the diagnosis of early breast carcinoma.
Methods:
Between 2011 and 2016, 136 patients with early breast cancer were analyzed and their tumor size on US and MRI findings were compared with their pathologic tumor size retrospectively. The background parenchymal enhancement of MRI was categorized as minimal, mild, moderate, and extreme. The patients who underwent neoadjuvant chemotherapy, had positive resection margins, underwent excisional biopsy for cancer diagnosis, and had non-mass lesions on MRI scans, were excluded.
Results:
In all, 83.1% of the cases showed concordance between MRI findings and pathologic tumor size within 0.5cm. MRI overestimated the findings by 10.3% and underestimated them by 6.6%; 78.7% showed concordance between US findings and pathologic tumor size within 0.5cm. US overestimated the findings by 5.9% and underestimated them by 15.4%. The tumor size on MRI (r=0.87) showed a stronger correlation to the pathologic tumor size than that on US (r=0.64) in early breast cancer patients. US had a tendency to underestimate the tumor size. The degree of breast parenchyma did not affect the accuracy of the measurement of preoperative tumor size.
Conclusion
MRI is relatively more accurate than US for assessing preoperative tumor size in breast cancer patients. US tends to underestimate tumor size.
10.A case of simultaneously identified glycogen storage disease and mucopolysaccharidosis.
Ju Young LEE ; Jeong Ok SHIM ; Hye Ran YANG ; Ju Young CHANG ; Choong Ho SHIN ; Jae Sung KO ; Jeong Kee SEO ; Woo Sun KIM ; Gyeong Hoon KANG ; Jeong Han SONG ; Jong Won KIM
Korean Journal of Pediatrics 2008;51(6):650-654
Glycogen storage disease (GSD) and mucopolysaccharidosis (MPS) are both independently inherited disorders. GSD is a member of a group of genetic disorders involving enzymes responsible for the synthesis and degradation of glycogen. GSD leads to abnormal tissue concentrations of glycogen, primarily in the liver, muscle, or both. MPS is a member of a group of inherited lysosomal storage diseases, which result from a deficiency in specific enzymatic activities and the accumulation of partially degraded acid mucopolysaccharides. A case of a 16-month-old boy who presented with hepatomegaly is reported. The liver was four finger-breadth-palpable. A laboratory study showed slightly increased serum AST and ALT levels. The liver biopsy showed microscopic features compatible with GSD. The liver glycogen content was 9.3% which was increased in comparison with the reference limit, but the glucose-6-phosphatase activity was within the normal limit. These findings suggested GSD other than type I. Bony abnormalities on skeletal radiographs, including an anterior beak and hook-shaped vertebrae, were seen. The mucopolysaccharide concentration in the urine was increased and the plasma iduronate sulfatase activity was low, which fulfilled the diagnosis criteria for Hunter syndrome (MPS type II). To the best of the authors' knowledge, this is the first case of GSD and Hunter syndrome being identified at the same time.
Animals
;
Beak
;
Biopsy
;
Glucose-6-Phosphatase
;
Glycogen
;
Glycogen Storage Disease
;
Glycosaminoglycans
;
Hepatomegaly
;
Humans
;
Iduronate Sulfatase
;
Infant
;
Liver
;
Liver Glycogen
;
Lysosomal Storage Diseases
;
Mucopolysaccharidoses
;
Mucopolysaccharidosis II
;
Muscles
;
Plasma
;
Spine